Basel Medical Group Ltd Ordinary Shares (BMGL) vs Gelteq Limited Ordinary Shares (GELS)
A side-by-side comparison of Basel Medical Group Ltd Ordinary Shares and Gelteq Limited Ordinary Shares across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BMGL
Basel Medical Group Ltd Ordinary Shares
$3.17HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
GELS
Gelteq Limited Ordinary Shares
$0.54HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — BMGL vs GELS
growth of $100 · dividends reinvested · last 2yBMGL -94.1% (-75.6%/yr)GELS -68.0% (-43.4%/yr)GELS compounded faster over this window
Log scale — wide-divergence pair
BMGL GELS
BMGL vs GELS: by the numbers
- •GELS is the larger company ($5M vs $5M market cap).
- •Both run net losses; BMGL's is the smaller (-106.78% vs -4011.86% net margin).
Metrics side by side
Valuation
| Metric | BMGL | GELS |
|---|---|---|
| P/B ratio | 1.02 | 0.53 |
Profitability
| Metric | BMGL | GELS |
|---|---|---|
| Gross margin | 77.68% | 100.00% |
| Operating margin | -19.28% | -3317.65% |
| Net margin | -106.78% | -4011.86% |
| ROE | -248.66% | -42.05% |
| ROIC | -35.07% | -27.41% |
Go deeper
Dig into the metrics
Basel Medical Group Ltd Ordinary Shares ROEGelteq Limited Ordinary Shares ROEBasel Medical Group Ltd Ordinary Shares operating marginGelteq Limited Ordinary Shares operating marginBasel Medical Group Ltd Ordinary Shares revenue growthGelteq Limited Ordinary Shares revenue growthBasel Medical Group Ltd Ordinary Shares free cash flowGelteq Limited Ordinary Shares free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.